PTC Therapeutics stockPTCT
PTC Therapeutics trades at $65.67, 27.7% below its 52-week high (Jul 9, 2026). The price is above its 50-day but below its 200-day average: a bounce within a downtrend. −13.5% year to date, −8.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 23, 2027.
Ratings, candles, signals and the screener for PTCT — after you log in
Open the terminalFrequently asked questions about PTC Therapeutics
What is the PTC Therapeutics stock price?
At the close on Nov 5, 2026: $65.67 (−4.78% on the day). 52-week high: $90.87 on Jul 9, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does PTC Therapeutics report earnings?
The next quarterly report is on Feb 23, 2027. Last quarter, earnings per share changed −410% year over year, revenue +70%.
Does PTC Therapeutics pay dividends?
No, PTC Therapeutics does not pay dividends.
Where does PTC Therapeutics trade and how to buy it?
Ticker PTCT, exchange Nasdaq, listed since 2013. You can buy it through a broker with access to US exchanges.
Should I buy PTC Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for PTCT are in the terminal after you log in.